Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis-Reference-Cited by-同舟云学术

Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis

Published:2016-06-03 Issue:11 Volume:36 Page:1677-1687
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

He Wei¹²,Li Binkui¹²,Zheng Yun¹²,Zou Ruhai¹³,Shen Jingxian¹⁴,Cheng Donghui¹²,Tao Qiang¹²,Liu Wenwu¹²,Li Qijiong¹²,Chen Guihua⁵,Yuan Yunfei¹²

Affiliation:

1. State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine; Sun Yat-Sen University Cancer Center; Guangzhou China

2. Department of Hepatobiliary Oncology; Sun Yat-Sen University Cancer Center; Guangzhou China

3. Department of Ultrasound; Sun Yat-Sen University Cancer Center; Guangzhou China

4. Department of Medical Imaging; Sun Yat-Sen University Cancer Center; Guangzhou China

5. Department of Surgery; The Third Affiliated Hospital of Sun Yat-sen University; Guangzhou China

Funder

National Natural Science Foundation of China

Sun Yat-Sen University Clinical Research 5010 Program

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13166/fullpdf

Reference34 articles.

1. Global cancer statistics;Adam;CA,2011

2. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review;Lau;Ann Surg,2009

3. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria;Huang;Ann Surg,2010

4. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma;Feng;J Hepatol,2012

5. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey;Hasegawa;J Hepatol,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) – Part I – Surgical treatments;Digestive and Liver Disease;2024-02

2. Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence;Journal of Cancer Research and Clinical Oncology;2023-08-26

3. Early recurrence of hepatocellular carcinoma in patients after ablation and resection: A propensity score analysis;The American Journal of Surgery;2023-08

4. Virtual Treatment Zone From Cone Beam CT Commonly Alters Treatment Plan and Identifies Tumor at Risk for Under-Treatment in US or US Fusion-Guided Microwave Ablation of Liver Tumors;Technology in Cancer Research & Treatment;2023-01

5. Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation;BMC Cancer;2022-02-28